Offers transparent pricing and tools for prescription management to reduce costs and improve medication access.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
SmithRx is a pharmacy benefits manager (PBM) that emphasizes transparency and affordability in prescription drug services. They provide employers and members with clear pricing, ensuring full savings and a people-first approach. Their platform offers accessible tools for managing prescriptions, including mobile-friendly portals and digital member cards. Additionally, SmithRx partners with thousands of pharmacies nationwide to expand access to affordable medications.
SmithRx Funding
Sign up to gain insights into SmithRx funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Nov 15, 2023 | 60M | ||
| Series B | Feb 02, 2022 | 20M | ||
| Series B | Feb 02, 2022 | 4M | ||
| Series B | Feb 02, 2022 | 4M | ||
| Series B | Mar 28, 2019 | 6M | ||
| Series A | Jan 31, 2018 | 3M | ||
| Series A | Jan 31, 2018 | 9M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
SmithRx Management Team
Investors
Venrock
Founders Fund
NextGen Venture Partners
Great Oaks Venture Capital
Box Group
Blumberg Capital
SmithRx Valuations & Financials
View real-time NPM data on SmithRx stock including daily SmithRx stock price estimates, valuation history, and historical share price information. Access SmithRx financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track SmithRx pricing across six independent market signals. Looking for private company due diligence data sources on SmithRx? Get in touch to learn more.
Similar Companies
like SmithRx
FAQ
We have answers
SmithRx stock does not trade on public stock exchanges. SmithRx stock is considered a private security and you need to be an accredited investor to trade shares. To invest in SmithRx stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
SmithRx Stock does not trade on public stock exchanges. In order to sell SmithRx shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
SmithRx does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view SmithRx share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for SmithRx stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell SmithRx stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in SmithRx stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
SmithRx is a private company and has not had an IPO. There is currently no SmithRx IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to SmithRx IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
